Results 291 to 300 of about 2,136,839 (361)
Some of the next articles are maybe not open access.

Letter: to switch or not to switch, that is the question

Alimentary Pharmacology & Therapeutics, 2022
LINKED CONTENTThis article is linked to Bergqvist et al papers.
Clément Bresteau   +2 more
openaire   +2 more sources

To Switch or Not To Switch

American Behavioral Scientist, 2014
The authors designed and ran an experiment to measure social influence in online recommender systems, specifically, how often people’s choices are changed by others’ recommendations when facing different levels of confirmation and conformity pressures.
Haiyi Zhu, Bernardo A. Huberman
openaire   +1 more source

The Box Problem: To Switch or Not to Switch [PDF]

open access: possibleMathematics Magazine, 1995
(1995). The Box Problem: To Switch or Not to Switch. Mathematics Magazine: Vol. 68, No. 1, pp. 27-34.
Brams, Steven J., Kilgour, D. Marc
openaire   +1 more source

To SWiTCH or not to SWiTCH?

Blood, 2012
In this issue of Blood, Ware and Helms report results from the Stroke With Transfusions Changing To Hydroxyurea (SWiTCH) study designed to determine whether hydroxyurea is as effective as transfusions in preventing recurrent strokes in children with sickle cell anemia.
Haiyi Zhu   +2 more
openaire   +3 more sources

In-memory computing with resistive switching devices

Nature Electronics, 2018
Modern computers are based on the von Neumann architecture in which computation and storage are physically separated: data are fetched from the memory unit, shuttled to the processing unit (where computation takes place) and then shuttled back to the ...
D. Ielmini, H. Wong
semanticscholar   +1 more source

Ferroelectric switching of a two-dimensional metal

Nature, 2018
A ferroelectric is a material with a polar structure whose polarity can be reversed (switched) by applying an electric field1,2. In metals, itinerant electrons screen electrostatic forces between ions, which explains in part why polar metals are very ...
Zaiyao Fei   +8 more
semanticscholar   +1 more source

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.

The Lancet, 2017
BACKGROUND TNF inhibitors have improved treatment of Crohn's disease, ulcerative colitis, spondyloarthritis, rheumatoid arthritis, psoriatic arthritis, and chronic plaque psoriasis, but are expensive therapies.
K. Jørgensen   +4 more
semanticscholar   +1 more source

To switch (statins) or not to switch? That is the question

Expert Opinion on Pharmacotherapy, 2010
Cost is an important consideration when deciding which drugs to prescribe. The problem is becoming more evident because effective, well-tolerated and evidence-based generic drugs are now widely available. More specifically, switching to a cheaper statin formulation might result in less effective treatment in terms of event reduction or achievement of ...
Vasilios G, Athyros   +3 more
openaire   +2 more sources

Switching Phenomena in a System with No Switches

Journal of Statistical Physics, 2010
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Preis, Tobias, Stanley, H. Eugene
openaire   +2 more sources

To switch or not to switch: that is the biosimilar question

Nature Reviews Gastroenterology & Hepatology, 2017
Biosimilar monoclonal antibodies are now being accepted in clinical practice by IBD specialists. However, switching patients already undergoing originator biologic treatment to biosimilars has been debated due to lack of controlled studies. The NOR-SWITCH study now provides novel clinical evidence in switching from originator to biosimilar in patients ...
Danese S, Peyrin-Biroulet L
openaire   +3 more sources

Home - About - Disclaimer - Privacy